Human MAP2K5/HsT17454/MAPKK5 ORF/cDNA clone-Adenovirus particle (BC008838)

Cat. No.: vGMAP000395

Pre-made Human MAP2K5/HsT17454/MAPKK5 Adenovirus for MAP2K5 overexpression in-vitro and in-vivo. The MAP2K5 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified MAP2K5-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.

At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.

Target products collection

Go to MEK5/MAP2K5/MAP2K5/HsT17454 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name Adenovirus Grade Adenovirus quantity
vGMAP000395 Human MAP2K5 Adenovirus particle Research Grade-In vitro 1E+10PFU (1E+10pfu/ml×1ml)
5E+10PFU (1E+10pfu/ml×5ml)
1E+11PFU (1E+10pfu/ml×10ml)
Research Grade-In vivo 1E+11PFU (1E+11pfu/ml×1ml)
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAP000395
Gene Name MAP2K5
Accession Number BC008838
Gene ID 5607
Species Human
Product Type Adenovirus particle (overexpression)
Insert Length 1347 bp
Gene Alias HsT17454,MAPKK5,MEK5
Fluorescent Reporter GFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Amplicin
ORF Nucleotide Sequence ATGCTGTGGCTAGCCCTTGGCCCCTTTCCTGCCATGGAGAACCAGGTGCTGGTAATTCGCATCAAGATCCCAAATAGTGGCGCGGTGGACTGGACAGTGCACTCCGGGCCGCAGTTACTCTTCAGGGATGTGCTGGATGTGATAGGCCAGGTTCTGCCTGAAGCAACAACTACAGCATTTGAATATGAAGATGAAGATGGTGATCGAATTACAGTGAGAAGTGATGAGGAAATGAAGGCAATGCTGTCATATTATTATTCCACAGTAATGGAACAGCAAGTAAATGGACAGTTAATAGAGCCTCTGCAGATATTTCCAAGAGCCTGCAAGCCTCCTGGGGAACGGAACATACATGGCCTGAAGGTGAATACTCGGGCCGGACCCTCTCAACACAGCAGCCCAGCAGTCTCAGATTCACTTCCAAGCAATAGCTTAAAGAAGTCTTCTGCTGAACTGAAAAAAATACTAGCCAATGGCCAGATGAATGAACAAGACATACGATATCGGGACACTCTTGGTCATGGCAACGGAGGCACAGTCTACAAAGCATATCATGTCCCGAGTGGGAAAATATTAGCTGTAAAGGTCATACTACTAGATATTACACTGGAACTTCAGAAGCAAATTATGTCTGAATTGGAAATTCTTTATAAGTGCGATTCATCATATATCATTGGATTTTATGGAGCATTTTTTGTAGAAAACAGGATTTCAATATGTACAGAATTCATGGATGGGGGATCTTTGGATGTATATAGGAAAATGCCAGAACATGTCCTTGGAAGAATTGCAGTAGCAGTTGTTAAAGGCCTTACTTATTTGTGGAGTTTAAAGATTTTACATAGAGACGTGAAGCCCTCCAATATGCTAGTAAACACAAGAGGACAGGTTAAGCTGTGTGATTTTGGAGTTAGCACTCAGCTGGTGAATTCTATAGCCAAGACGTATGTTGGAACAAATGCTTATATGGCGCCTGAAAGGATTTCAGGGGAGCAGTATGGAATTCATTCTGATGTCTGGAGCTTAGGAATCTCTTTTATGGAGCTTGCTCTTGGGAGGTTTCCATATCCTCAGATTCAGAAAAACCAGGGATCTTTAATGCCTCTCCAGCTTCTGCAGTGCATTGTTGATGAGGATTCGCCCGTCCTTCCAGTTGGAGAGTTCTCGGAGCCATTTGTACATTTCATCACTCAGTGTATGCGAAAACAGCCAAAAGAAAGGCCAGCACCTGAAGAATTGATGGGCCACCCGTTCATCGTGCAGTTCAATGATGGAAATGCCGCCGTGGTGTCCATGTGGGTGTGCCGGGCGCTGGAGGAGAGGCGGAGCCAGCAGGGGCCCCCGTGA
ORF Protein Sequence MLWLALGPFPAMENQVLVIRIKIPNSGAVDWTVHSGPQLLFRDVLDVIGQVLPEATTTAFEYEDEDGDRITVRSDEEMKAMLSYYYSTVMEQQVNGQLIEPLQIFPRACKPPGERNIHGLKVNTRAGPSQHSSPAVSDSLPSNSLKKSSAELKKILANGQMNEQDIRYRDTLGHGNGGTVYKAYHVPSGKILAVKVILLDITLELQKQIMSELEILYKCDSSYIIGFYGAFFVENRISICTEFMDGGSLDVYRKMPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDSPVLPVGEFSEPFVHFITQCMRKQPKERPAPEELMGHPFIVQFNDGNAAVVSMWVCRALEERRSQQGPP

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T17143-Ab Anti-MAP2K5 monoclonal antibody
    Target Antigen GM-Tg-g-T17143-Ag MAP2K5 protein
    ORF Viral Vector pGMLP000477 Human MAP2K5 Lentivirus plasmid
    ORF Viral Vector pGMLP005317 Human MAP2K5 Lentivirus plasmid
    ORF Viral Vector pGMLP005804 Human MAP2K5 Lentivirus plasmid
    ORF Viral Vector pGMAP000395 Human MAP2K5 Adenovirus plasmid
    ORF Viral Vector vGMLP000477 Human MAP2K5 Lentivirus particle
    ORF Viral Vector vGMLP005317 Human MAP2K5 Lentivirus particle
    ORF Viral Vector vGMLP005804 Human MAP2K5 Lentivirus particle
    ORF Viral Vector vGMAP000395 Human MAP2K5 Adenovirus particle


    Target information

    Target ID GM-T17143
    Target Name MEK5/MAP2K5
    Gene Group Identifier
    （Target Gene ID in Homo species)         		5607
    Gene ID 100052849 (Equus caballus), 100295732 (Bos taurus), 101100725 (Felis catus), 23938 (Mus musculus)
    29568 (Rattus norvegicus), 5607 (Homo sapiens), 609559 (Canis lupus familiaris), 711672 (Macaca mulatta)
    Gene Symbols & Synonyms MAP2K5,Map2k5,MEK5,Mapkk5,Prkmk5,Mek5,MAPKK5,PRKMK5,HsT17454
    Target Alternative Names Dual specificity mitogen-activated protein kinase kinase 5,HsT17454,MAP kinase kinase 5,MAP2K5,MAPK/ERK kinase 5 (MEK 5),MAPKK 5,MAPKK5,MEK5,Map2k5,Mapkk5,Mek5,PRKMK5,Prkmk5
    Uniprot Accession Q13163,Q62862,Q9WVS7
    Additional SwissProt Accessions: Q9WVS7,Q62862,Q13163
    Uniprot Entry Name
    Protein Sub-location Introcelluar Protein
    Category Therapeutics Target
    Disease
    Disease from KEGG MAPK signaling pathway, Gap junction, Neurotrophin signaling pathway, Oxytocin signaling pathway, Fluid shear stress and atherosclerosis
    Gene Ensembl ENSECAG00000022411, ENSBTAG00000000218, ENSMUSG00000058444, ENSG00000137764, ENSCAFG00845017514, ENSMMUG00000014482
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.